Search results
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 14 hours agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
These Pictures Will Help You Identify the Most Common Skin Rashes
Prevention via Yahoo News· 3 hours agoFrom eczema to allergic reactions to bug bites, here’s what common skin rashes look like in photos,...
Does the Anti-Inflammatory Diet for Psoriasis Help Manage Symptoms?
Verywell Health via Yahoo News· 4 days agoInflammation is one of the underlying causes of psoriasis, and research shows that an...
VB man sentenced in major coupon fraud scheme denied early release
WAVY via Yahoo News· 23 hours agoA Virginia Beach man sentenced for his involvement in his wife's $31 million-plus counterfeit coupon...
Joint Pain in Big Toe: Possible Causes and Treatment
Healthline· 4 days agoConsider the following possible causes of joint pain in your big toe, including symptoms, risk factors, and prevention strategies. A type of arthritis,...
20 30-Minute Mediterranean Diet Dinners for Spring
Eating Well via Yahoo News· 4 days agoShe created this recipe for Lemongrass-&-Coconut Poached Salmon exclusively for EatingWell. It features a trifecta of inflammation-fighting...
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of...
WPRI Providence· 1 day agoFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and reminds investors ...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 3 days agoOctober 2023, the FDA approved Cosentyx for treating moderate-to-severe hidradenitis suppurativa...
VTYX IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc....
FOX 5 San Diego· 6 days agoWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant and/or traceable to the offering documents ...
FDA Approval of Alvotech/Teva Ustekinumab Biosimilar | JD Supra
JD Supra· 4 days agoOn April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson’s STELERA® (ustekinumab). The product was approved as a subcutaneous ...